CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,054 | -17.9% | 1,984 | +1.6% | 0.00% | -50.0% |
Q2 2023 | $109,641 | +21.9% | 1,953 | -1.8% | 0.00% | +100.0% |
Q1 2023 | $89,917 | +10.2% | 1,988 | -1.0% | 0.00% | 0.0% |
Q4 2022 | $81,625 | -34.7% | 2,008 | +5.0% | 0.00% | -50.0% |
Q3 2022 | $125,000 | +5.9% | 1,913 | -1.6% | 0.00% | 0.0% |
Q2 2022 | $118,000 | +4.4% | 1,944 | +8.2% | 0.00% | 0.0% |
Q1 2022 | $113,000 | +113.2% | 1,796 | +155.5% | 0.00% | +100.0% |
Q4 2021 | $53,000 | -55.1% | 703 | -33.1% | 0.00% | -50.0% |
Q3 2021 | $118,000 | -58.9% | 1,051 | -40.6% | 0.00% | -60.0% |
Q2 2021 | $287,000 | -100.0% | 1,770 | -78.7% | 0.01% | -44.4% |
Q1 2021 | $1,012,330,000 | +722992.9% | 8,308 | +806.0% | 0.01% | +200.0% |
Q4 2020 | $140,000 | +351.6% | 917 | +145.8% | 0.00% | +200.0% |
Q3 2020 | $31,000 | +40.9% | 373 | +24.3% | 0.00% | 0.0% |
Q2 2020 | $22,000 | +83.3% | 300 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -33.3% | 300 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $18,000 | +50.0% | 300 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $13,000 | +116.7% | 300 | +200.0% | 0.00% | – |
Q2 2018 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |